Genky DrugStores Co., Ltd. Statistics
Want to see JP:9267 full AI Analyst Report?
Genky DrugStores Co., Ltd. (9267) Stock Statistics & Valuation Metrics
Total Valuation
Genky DrugStores Co., Ltd. has a market cap or net worth of JPY 114.83B. The enterprise value is JPY 132.56B.
- Market Cap
- JPY 114.83B
- Enterprise Value
- JPY 132.56B
Share Statistics
Genky DrugStores Co., Ltd. has 31,044,567 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 31,044,567
- Owned by Insiders
- ―
- Owned by Institutions
- 11.82%
Financial Efficiency
Genky DrugStores Co., Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 7.36%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 7.36%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 35.07M
- Profits Per Employee
- 1.25M
- Employee Count
- 6,291
- Asset Turnover
- 1.52
- Inventory Turnover
- 6.13
Valuation Ratios
The current PE Ratio of Genky DrugStores Co., Ltd. is 15.00. Genky DrugStores Co., Ltd.’s PEG ratio is 6.52.
- PE Ratio
- 15.00
- PS Ratio
- 0.52
- PB Ratio
- 1.84
- Price to FCF
- -100.26
- Price to Operating Cash Flow
- 31.04
- PEG Ratio
- 6.52
Income Statement
In the last 12 months, Genky DrugStores Co., Ltd. had revenue of 220.64B and earned 7.88B in profits. Earnings per share was 258.51.
- Revenue
- 220.64B
- Gross Profit
- 44.92B
- Operating Income
- 10.98B
- Pretax Income
- 11.15B
- Net Income
- 7.88B
- EBITDA
- 18.12B
- Earnings Per Share (EPS)
- 258.51
Cash Flow
In the last 12 months, operating cash flow was 3.73B and capital expenditures -4.89B, giving a free cash flow of -1.16B billion.
- Operating Cash Flow
- 3.73B
- Free Cash Flow
- -1.16B
- Free Cash Flow per Share
- -37.86
Dividends & Yields
Genky DrugStores Co., Ltd. pays an annual dividend of JPY 6.50, resulting in a dividend yield of 0.35%
- Dividend Per Share
- JPY 6.50
- Dividend Yield
- 0.35%
- Payout Ratio
- 5.03%
- Free Cash Flow Yield
- -1.01%
- Earnings Yield
- 6.77%
Stock Price Statistics
- Beta
- 0.49
- 52-Week Price Change
- -26.19%
- 50-Day Moving Average
- 3504.70
- 200-Day Moving Average
- 3714.38
- Relative Strength Index (RSI)
- 57.29
- Average Volume (3m)
- 79.02K
Important Dates
Genky DrugStores Co., Ltd. upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Feb 02, 2027
- Ex-Dividend Date
- Jun 17, 2027
Financial Position
Genky DrugStores Co., Ltd. as a current ratio of 0.93, with Debt / Equity ratio of 64.59%
- Current Ratio
- 0.93
- Quick Ratio
- 0.35
- Debt to Market Cap
- 0.38
- Net Debt to EBITDA
- 1.75
- Interest Coverage Ratio
- 35.10
Taxes
In the past 12 months, Genky DrugStores Co., Ltd. has paid 3.28B in taxes.
- Income Tax
- 3.28B
- Effective Tax Rate
- 0.29
Enterprise Valuation
Genky DrugStores Co., Ltd. EV to EBITDA ratio is 7.62, with an EV/FCF ratio of -121.65.
- EV to Sales
- 0.63
- EV to EBITDA
- 7.62
- EV to Free Cash Flow
- -121.65
- EV to Operating Cash Flow
- 37.67
Balance Sheet
Genky DrugStores Co., Ltd. has JPY 13.93B in cash and marketable securities with JPY 40.47B in debt, giving a net cash position of -JPY 26.55B billion.
- Cash & Marketable Securities
- JPY 13.93B
- Total Debt
- JPY 40.47B
- Net Cash
- -JPY 26.55B
- Net Cash Per Share
- -JPY 855.09
- Tangible Book Value Per Share
- JPY 2,058.07
Margins
Gross margin is 20.38%, with operating margin of 4.83%, and net profit margin of 3.44%.
- Gross Margin
- 20.38%
- Operating Margin
- 4.83%
- Pretax Margin
- 4.88%
- Net Profit Margin
- 3.44%
- EBITDA Margin
- 8.23%
- EBIT Margin
- 4.94%
Analyst Forecast
The average price target for Genky DrugStores Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 8.38%
- EPS Growth Forecast
- 2.29%
Scores
- Smart Score
- ―
- AI Score
- 65

